Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
- PMID: 16543145
- DOI: 10.1016/j.molcel.2006.02.009
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
Abstract
We investigated the role of glycogen synthase kinase-3 (GSK-3), which is inactivated by AKT, for its role in the regulation of apoptosis. Upon IL-3 withdrawal, protein levels of MCL-1 decreased but were sustained by pharmacological inhibition of GSK-3, which prevented cytochrome c release and apoptosis. MCL-1 was phosphorylated by GSK-3 at a conserved GSK-3 phosphorylation site (S159). S159 phosphorylation of MCL-1 was induced by IL-3 withdrawal or PI3K inhibition and prevented by AKT or inhibition of GSK-3, and it led to increased ubiquitinylation and degradation of MCL-1. A phosphorylation-site mutant (MCL-1(S159A)), expressed in IL-3-dependent cells, showed enhanced stability upon IL-3 withdrawal and conferred increased protection from apoptosis compared to wild-type MCL-1. The results demonstrate that the control of MCL-1 stability by GSK-3 is an important mechanism for the regulation of apoptosis by growth factors, PI3K, and AKT.
Comment in
-
Growth factor withdrawal and apoptosis: the middle game.Mol Cell. 2006 Mar 17;21(6):728-30. doi: 10.1016/j.molcel.2006.03.005. Mol Cell. 2006. PMID: 16543140 Review.
Similar articles
-
Growth factor withdrawal and apoptosis: the middle game.Mol Cell. 2006 Mar 17;21(6):728-30. doi: 10.1016/j.molcel.2006.03.005. Mol Cell. 2006. PMID: 16543140 Review.
-
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.Int J Oncol. 2007 Apr;30(4):905-18. Int J Oncol. 2007. PMID: 17332930
-
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.J Cell Physiol. 2009 Jul;220(1):58-71. doi: 10.1002/jcp.21730. J Cell Physiol. 2009. PMID: 19229877
-
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.J Natl Cancer Inst. 2008 Apr 16;100(8):580-95. doi: 10.1093/jnci/djn076. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398104
-
Mcl-1.Int J Biochem Cell Biol. 2005 Feb;37(2):267-71. doi: 10.1016/j.biocel.2004.04.007. Int J Biochem Cell Biol. 2005. PMID: 15474972 Review.
Cited by
-
Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies.Int J Mol Sci. 2024 Jun 8;25(12):6356. doi: 10.3390/ijms25126356. Int J Mol Sci. 2024. PMID: 38928061 Free PMC article. Review.
-
Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.J Clin Invest. 2015 Mar 2;125(3):1081-97. doi: 10.1172/JCI75821. Epub 2015 Feb 2. J Clin Invest. 2015. PMID: 25642772 Free PMC article.
-
Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice.J Biol Chem. 2015 Apr 24;290(17):10934-46. doi: 10.1074/jbc.M114.602284. Epub 2015 Mar 9. J Biol Chem. 2015. PMID: 25752611 Free PMC article.
-
Modulation of GSK-3β activity in Venezuelan equine encephalitis virus infection.PLoS One. 2012;7(4):e34761. doi: 10.1371/journal.pone.0034761. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496857 Free PMC article.
-
JAK2V617F drives Mcl-1 expression and sensitizes hematologic cell lines to dual inhibition of JAK2 and Bcl-xL.PLoS One. 2015 Mar 17;10(3):e0114363. doi: 10.1371/journal.pone.0114363. eCollection 2015. PLoS One. 2015. PMID: 25781882 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
